Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.770
-0.045 (-1.60%)
Nov 21, 2024, 1:24 PM EST - Market open
Galectin Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 174 | 103 | 67 | 123 | 128 | 163 | |
| Market Cap Growth | 49.71% | 52.89% | -45.33% | -3.92% | -21.42% | 15.30% | |
| Enterprise Value | 256 | 147 | 84 | 109 | 98 | 115 | |
| Last Close Price | 2.81 | 1.66 | 1.13 | 2.07 | 2.24 | 2.86 | |
| PB Ratio | -1.85 | -1.70 | -2.09 | 46.96 | 5.28 | 3.57 | |
| P/TBV Ratio | - | - | - | 335.62 | 5.83 | 3.75 | |
| Debt / Equity Ratio | -1.13 | -1.19 | -1.24 | 11.11 | 0.00 | 0.00 | |
| Quick Ratio | 1.07 | 1.64 | 1.43 | 4.39 | 5.03 | 16.84 | |
| Current Ratio | 1.13 | 1.77 | 1.58 | 4.63 | 5.46 | 17.10 | |
| Return on Equity (ROE) | - | - | - | -227.74% | -67.25% | -50.65% | |
| Return on Assets (ROA) | -96.72% | -96.17% | -75.96% | -52.81% | -37.54% | -29.23% | |
| Return on Capital (ROIC) | -207.88% | -246.50% | -121.64% | -67.46% | -41.94% | -31.98% | |
| Earnings Yield | -25.32% | -40.00% | -57.74% | -24.85% | -18.35% | -8.17% | |
| FCF Yield | -18.85% | -32.11% | -46.25% | -19.79% | -16.11% | -6.67% | |
| Buyback Yield / Dilution | -4.27% | -1.29% | -1.48% | -2.63% | -9.17% | -32.54% | |
| Total Shareholder Return | -4.27% | -1.29% | -1.48% | -2.63% | -9.17% | -32.54% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.